SCHEMBL7366844

SCHEMBL7366844

O=CCCCCCCOc1cccc(-c2ccccc2)c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 5/20 0.57
HDAC2 Q92769 5/20 0.57
HRH3 Q9Y5N1 7/20 0.55
HDAC8 Q9BY41 3/20 0.51
HDAC6 Q9UBN7 3/20 0.51
HDAC3 O15379 1/20 0.51
HDAC4 P56524 1/20 0.51
HDAC7 Q8WUI4 1/20 0.51
HDAC10 Q969S8 1/20 0.51
HDAC11 Q96DB2 1/20 0.51
HDAC9 Q9UKV0 1/20 0.51
HDAC5 Q9UQL6 1/20 0.51
LTA4H P09960 1/20 0.49
FFAR1 O14842 2/20 0.48
FFAR4 Q5NUL3 1/20 0.48
BACE1 P56817 1/20 0.48
MRGPRX4 Q96LA9 1/20 0.47
KCNA3 P22001 1/20 0.46
PPARG P37231 1/20 0.45
PPARD Q03181 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5254178 0.89 LTA4H (0.53) HDAC1HDAC2HRH3HDAC8HDAC6
SCHEMBL7371053 0.85 HDAC1 (0.58) HDAC1HDAC2HRH3HDAC8HDAC6
SCHEMBL7373189 0.85 HDAC1 (0.58) HDAC1HDAC2HRH3HDAC8HDAC6
SCHEMBL7500091 0.85 KCNA3 (0.64) HDAC1HDAC2HDAC8HDAC6HDAC3
SCHEMBL2786288 0.85 KCNA3 (0.64) HDAC1HDAC2HDAC8HDAC6HDAC3
SCHEMBL96055 0.85 KCNA3 (0.64) HDAC1HDAC2HDAC8HDAC6HDAC3
SCHEMBL1172269 0.85 KCNA3 (0.64) HDAC1HDAC2HDAC8HDAC6HDAC3
SCHEMBL5593684 0.85 KCNA3 (0.64) HDAC1HDAC2HDAC8HDAC6HDAC3
SCHEMBL9683773 0.85 KCNA3 (0.64) HDAC1HDAC2HDAC8HDAC6HDAC3
SCHEMBL96602 0.83 KCNA3 (0.67) HDAC1HDAC2HDAC8HDAC6HDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020177594-A1 Inhibitors of histone deacetylase ABBOTT LABORATORIES 2002-11-28 US disclosed
WO-2002046129-A2 INHIBITORS OF HISTONE DEACETYLASE ABBOTT LABORATORIES (US) 2002-06-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020177594-A1 Inhibitors of histone deacetylase HDAC1, HDAC11, HDAC3 HDAC1 1/4885HDAC2 4/4885HRH3 431/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.